Sign in

Julie Matte

@jcmatte.bsky.social
94 followers 259 following 9 posts

Scientist in the Trynka lab at the Wellcome Sanger Institute Interested in all things related to T cells, CRISPR and imaging Profile picture by Megan Gozzard

PostsRepliesMedia
Reposted by Julie Matte
Olivier Bakker @obbakker.bsky.social · 12/02/2026
Very happy to share our venture into the wild world of imaging is now out on biorxiv. It has been the start of a very interesting journey with lots of interesting learnings along the way. I for sure will never make the mistake of considering a Jurkat a proper T cell again :)
041
Julie Matte @jcmatte.bsky.social · 12/02/2026
Thrilled to share TGlow, our high‑content imaging platform for scalable single‑cell phenotyping of lymphocytes. It complements single‑cell omics by revealing what happens next inside the cell and does so at scale. Details in the thread & link to our preprint: www.biorxiv.org/content/10.6...
biorxiv.org
140
Reposted by Julie Matte
Open Targets @opentargets.org · 26/08/2025
Out now on bioRxiv! 🧬🖥️ A team from the Cowley, Bassett, and @gosiatrynka.bsky.social labs integrate pooled iPSC phenotyping, transcriptomics, and CRISPR perturbations to identify genetic drivers of molecular and cellular phenotypes in microglia www.biorxiv.org/content/10.1... #neuroskyence
biorxiv.org
Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk
Mounting evidence implicates microglia in neurodegeneration, but linking disease-associated genetic variants to target genes and cellular phenotypes is hindered by the inaccessibility of these cells. ...
0115
Reposted by Julie Matte
Fabian Theis @fabiantheis.bsky.social · 03/07/2025
New OpenProblems paper out! 📝 Led by Malte Lücken with Smita Krishnaswamy, we present openproblems.bio – a community-driven platform benchmarking single-cell analysis methods. Excited about transparent, evolving best practices for the field! 🔗 www.nature.com/articles/s41...
nature.com
Defining and benchmarking open problems in single-cell analysis - Nature Biotechnology
Nature Biotechnology - Defining and benchmarking open problems in single-cell analysis
0239
Reposted by Julie Matte
Adrian Liston @labliston.bsky.social · 21/06/2025
Pre-print time! Our new study on #systemsimmunology analysis of #Alzheimers patients is out now on @medrxivpreprint.bsky.social. This is the culmination of a long collaboration with Rik Vandenberghe, Stephanie Humblet-Baron and Lidia Yshii's labs at KU Leuven. 🧵1/8 www.medrxiv.org/content/10.1...
medrxiv.org
A systems immunology analysis of Alzheimer’s disease reveals an age- and environmental exposure-independent disturbance in B cell maturation
Alzheimer’s disease is a severe neurodegenerative disorder, with multifactorial mechanisms of disease development and progression. Evidence from genetic association studies, animal models, and clinica...
15921
Reposted by Julie Matte
Lucia Ramirez-Navarro @luciaramirez.bsky.social · 04/06/2025
🚨 SUPER EXCITED to share our new preprint on the mucosal and circulatory immune landscape of Crohn’s disease! 🩸 Blood is commonly used in biomarker discovery and drug development, but how well does it reflect what's actually happening in the gut? 👀 🧵 1/10 🔗 www.medrxiv.org/content/10.1...
medrxiv.org
Tissue-specific and circulatory immune signatures of mucosal inflammation in Crohn's disease
Crohn's disease (CD) is a heterogeneous disease characterized by chronic inflammation of the gastrointestinal tract driven by an aberrant immune response. To understand the immune mechanisms underlyin...
154
Reposted by Julie Matte
Tuuli Lappalainen @tuuliel.bsky.social · 06/05/2025
Our new contribution to the quest to find causal GWAS genes! Sam Ghatan from my lab at @nygenome.org led a systematic comparison of eQTLs and CRISPRi+scRNA-seq screens. TL;DR: they provide highly complementary insights, with ortogonal pros and cons. 🧵👇 www.biorxiv.org/content/10.1...
19842
Reposted by Julie Matte
Open Targets @opentargets.org · 02/05/2025
Out today in Nature Biotechnology! This Open Targets project created an atlas of tissue-specific protein associations for 11 human tissues, furthering our understanding of cell-type and tissue-specific function, and helping to prioritise more specific—and potentially safer—drug targets 🧬🖥️
0113
Reposted by Julie Matte
Magdalena Skipper @magdalenaskipper.bsky.social · 02/05/2025
Cell cycle duration determines oncogenic transformation capacity Tumours usually originate from a specific cell type in a given tissue; cell types that have faster cycles are more likely to become cancerous 🧪 www.nature.com/articles/s41...
nature.com
Cell cycle duration determines oncogenic transformation capacity - Nature
Total cell cycle duration is a key hallmark of cancer initiation, and determines whether defects in apoptosis, senescence, immune surveillance, angiogenesis, DNA repair, polarity and proliferation lea...
0179
Reposted by Julie Matte
Shicheng Guo @shihcheng.bsky.social · 02/05/2025
Explore human metabologenomics with GEMs, integrating 1000s of genes, proteins, and metabolites to uncover metabolism's mysteries! PMID:39300314, Nat Rev Genet 2025, @NatureRevGenet doi.org/10.1038/s41576-024-00768-0 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
doi.org
Genome-scale models in human metabologenomics | Nature Reviews Genetics
Metabologenomics integrates metabolomics with other omics data types to comprehensively study the genetic and environmental factors that influence metabolism. These multi-omics data can be incorporated into genome-scale metabolic models (GEMs), which are highly curated knowledge bases that explicitly account for genes, transcripts, proteins and metabolites. By including all known biochemical reactions catalysed by enzymes and transporters encoded in the human genome, GEMs analyse and predict the behaviour of complex metabolic networks. Continued advancements to the scale and scope of GEMs — from cells and tissues to microbiomes and the whole body — have helped to design effective treatments and develop better diagnostic tools for metabolic diseases. Furthermore, increasing amounts of multi-omics data are incorporated into GEMs to better identify the underlying mechanisms, biomarkers and potential drug targets of metabolic diseases. Metabologenomics integrates multi-omics data into geno
021
Reposted by Julie Matte
Nature Reviews Immunology @natrevimmunol.nature.com · 02/05/2025
NEW Review online by Morgan Huse @mskcancercenter.bsky.social looks at how mechanical forces contribute to the potency, specificity and efficacy of the cytotoxic lymphocyte response #immunosky
nature.com
Mechanoregulation of lymphocyte cytotoxicity - Nature Reviews Immunology
Cytotoxic T lymphocytes and natural killer cells destroy target cells using a mechanically active cytolytic immune synapse. This Review examines the various ways in which mechanical forces contribute ...
04017
Reposted by Julie Matte
Eric Topol @erictopol.bsky.social · 19/03/2025
How can B cells rapidly proliferate and have mutations suppressed? A longstanding mystery solved involving transient mutation suppression capability of germinal centers nature.com/articles/s41... www.nature.com/articles/s41...
nature.com
Regulated somatic hypermutation enhances antibody affinity maturation - Nature
Germinal centre B cells modify their mutation rate to preserve high-affinity receptors, thereby safeguarding high-affinity B cell lineages and enhancing the outcomes of antibody affinity maturation.
517635
Reposted by Julie Matte
Tim Coorens @timcoorens.bsky.social · 20/03/2025
The stomach is an organ unique in its function, environment and exposures. How does this affect the mutations that normal cells in the stomach acquire? What does this reveal about the origins of stomach cancer? These questions and more in our @nature.com paper: www.nature.com/articles/s41...
nature.com
The somatic mutation landscape of normal gastric epithelium - Nature
Whole-gene sequencing of microdissected gastric glands from individuals with and without gastric cancer reveals distinct patterns of somatic mutations and provides insights into influen...
34016
Reposted by Julie Matte
Adrian Liston @labliston.bsky.social · 18/03/2025
New research article from the lab led by the amazing @amydashwood.bsky.social ! In collaboration with @vib-switch-lab.bsky.social @cbdresearch.bsky.social we engineered variants of #IL2 designed for therapeutic use. 1/11 www.sciencedirect.com/science/arti...
sciencedirect.com
Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity
The pleotropic nature of interleukin-2 (IL2) has allowed it to be used as both a pro-inflammatory and anti-inflammatory therapeutic agent, through pro…
1369
Reposted by Julie Matte
Aylwyn Scally @aylwyn-scally.bsky.social · 18/03/2025
Our paper on ancient human population structure is now published. We find that the ancestors of modern humans lived in multiple populations during the period when Homo sapiens evolved in Africa. www.nature.com/articles/s41...
nature.com
A structured coalescent model reveals deep ancestral structure shared by all modern humans - Nature Genetics
The cobraa model extends the pairwise sequentially Markovian coalescent to identify structured population history by examination of the model transition matrix. Applied to human polymorphism data, cob...
212152
Reposted by Julie Matte
Sasha Gusev @sashagusevposts.bsky.social · 07/03/2025
Tomorrow is the last day to apply to the Leena Peltonen School of Human Genomics summer program (Wellcome Campus, UK) for scientists nearing the completion of their PhD. 1:1 mentorship from many fantastic tutors! lpshg.com/how-to-apply/
01916
Reposted by Julie Matte
Leopold Parts @leopoldparts.bsky.social · 31/01/2025
We're delighted to share our work on scrambling the human genome using prime editing, repetitive elements, and recombinases in @science.org , led by @jonaskoeppel.bsky.social , @f-raphael.bsky.social , with @proftomellis.bsky.social and George Church. www.science.org/doi/10.1126/...
science.org
Randomizing the human genome by engineering recombination between repeat elements
We lack tools to edit DNA sequences at scales necessary to study 99% of the human genome that is noncoding. To address this gap, we applied CRISPR prime editing to insert recombination handles into re...
213861
Reposted by Julie Matte
Jonathan Pritchard @jkpritch.bsky.social · 26/01/2025
Modern GWAS can identify 1000s of significant hits but it can be hard to turn this into biological insight. What key cellular functions link genetic variation to disease? I'm very excited to present our new work combining associations and Perturb-seq to build interpretable causal graphs! A 🧵
6318118
Reposted by Julie Matte
John Doench @johndoench.bsky.social · 18/01/2025
"The main question when reviewing a paper should be whether its conclusions are likely to be correct, not whether it would be important if it were true. Real advances are built with bricks, not straw." A perpetual must-read: www.nature.com/articles/545...
13611
Reposted by Julie Matte
Thomas Vanderstichele @tvdstichele.bsky.social · 20/01/2025
The Week in Bio #34. Research highlights from the week including randomisation of a super-enhancer, catalytic LYTACs from Lycia Therapeutics and de novo design of binders for snake venom. Link below.
154
Reposted by Julie Matte
Leopold Parts @leopoldparts.bsky.social · 15/01/2025
We are happy to share our enhancer scramble story, a strategy to create hundreds of stochastic deletions, inversions, and duplications within mammalian gene regulatory regions and associate these new architectures with gene expression levels 🧵 www.biorxiv.org/content/10.1...
Enhancer scrambling strategy
318376
Reposted by Julie Matte
Thomas Vanderstichele @tvdstichele.bsky.social · 14/01/2025
The Week in Bio #33. Research highlights from the week including saturation mutagenesis of 500 human protein domains from the Lehner lab, Profluent Bio’s latest deep learning model and predicting RNA-seq from DNA with Borzoi. weekinbio.substack.com/p/the-week-i...
weekinbio.substack.com
The Week in Bio #33
Research highlights from the week
062
Reposted by Julie Matte
Ewan Harrison @ewanharrison.bsky.social · 13/01/2025
Our paper investigating the mutational landscape during Staphylococcus aureus during colonisation is out now rdcu.be//d55l3 @fcic.bsky.social @sangerinstitute.bsky.social @ibv-csic.bsky.social University of Cambridge @julianparkhill.bsky.social
rdcu.be
The mutational landscape of Staphylococcus aureus during colonisation
Nature Communications - The authors applied a genomic and evolutionary approach to study Staphylococcus aureus in host adaptation during colonisation revealing signals of adaption in metabolic...
12212